Once we confirmed the binding of the fragments to purified recombinant TK1 and validated their specificity using a TK1 siRNA knockdown we proceeded to test their capacity to detect TK1 in cell lysates of different cancer cell lines, including, NCI-H460, HT-29, MDA-MB-231, PC3 and human MNC. This evidence concerns the gene TK1 and cancer.